Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine

被引：11
|
作者：
Booij, Jan [1 ]
Arbizu, Javier [2 ]
Darcourt, Jacques [3 ]
Hesse, Swen [4 ]
Nobili, Flavio [5 ]
Payoux, Pierre [6 ]
Pappata, Sabina [7 ]
Tatsch, Klaus [8 ]
Walker, Zuzana [9 ]
Pagani, Marco [10 ,11 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Navarra, Univ Navarra Clin, Dept Nucl Med, E-31080 Pamplona, Spain
[3] Univ Nice Sophia Antipolis, Dept Nucl Med, Ctr Antoine Lacassagne TIRO Lab CEA, F-06189 Nice, France
[4] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany
[5] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy
[6] Fac Med Toulouse, INSERM, F-31073 Toulouse, France
[7] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy
[8] Karlsruhe Inc, Municipal Hosp, Dept Nucl Med, Karlsruhe, Germany
[9] UCL, Dept Mental Hlth Sci Unit, London, England
[10] CNR, Inst Cognit Sci & Technol, Rome, Italy
[11] Karolinska Hosp, Dept Nucl Med, S-10401 Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷 / 07期
关键词：
EANM PROCEDURE GUIDELINES; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; FLORBETAPIR-PET; VERSION; PIB-PET; BETA; DEPOSITION; RADIOLIGAND; PATHOLOGY;
D O I：
10.1007/s00259-013-2415-x
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：1122 / 1125
页数：4
相关论文
共 11 条
  • [1] Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
    Johnson, Keith A.
    Minoshima, Satoshi
    Bohnen, Nicolaas I.
    Donohoe, Kevin J.
    Foster, Norman L.
    Herscovitch, Peter
    Karlawish, Jason H.
    Rowe, Christopher C.
    Carrillo, Maria C.
    Hartley, Dean M.
    Hedrick, Saima
    Pappas, Virginia
    Thies, William H.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (03) : 476 - 490
  • [2] Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
    Rabinovici, Gil D.
    Knopman, David S.
    Arbizu, Javier
    Benzinger, Tammie L. S.
    Donohoe, Kevin J.
    Hansson, Oskar
    Herscovitch, Peter
    Kuo, Phillip H.
    Lingler, Jennifer H.
    Minoshima, Satoshi
    Murray, Melissa E.
    Price, Julie C.
    Salloway, Stephen P.
    Weber, Christopher J.
    Carrillo, Maria C.
    Johnson, Keith A.
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
  • [3] Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET
    Altomare, Daniele
    Ferrari, Clarissa
    Festari, Cristina
    Guerra, Ugo Paolo
    Muscio, Cristina
    Padovani, Alessandro
    Friso, Giovanni B.
    Boccardi, Marina
    ALZHEIMERS & DEMENTIA, 2018, 14 (08) : 1088 - 1098
  • [4] Appropriate use criteria for dementia amyloid imaging in Switzerland - mini-review and statement on behalf of the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics
    Juengling, Freimut Dankwart
    Allenbach, Gilles
    Bruehlmeier, Matthias
    Klaeser, Bernd
    Wissmeyer, Michael Peter
    Garibotto, Valentina
    Felbecker, Ansgar
    Georgescu, Dan
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2021, 60 (01): : 7 - 9
  • [5] Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
    Chiotis, Konstantinos
    Carter, Stephen F.
    Farid, Karim
    Savitcheva, Irina
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (10) : 1492 - 1506
  • [6] Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study
    Segovia, Fermin
    Gomez-Rio, Manuel
    Sanchez-Vano, Raquel
    Manuel Gorriz, Juan
    Ramirez, Javier
    Trivino-Ibanez, Eva
    Carnero-Pardo, Cristobal
    Dolores Martinez-Lozano, Maria
    Sopena-Novales, Pablo
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (03) : 765 - 779
  • [7] Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project
    de Wilde, Arno
    Ossenkoppele, Rik
    Pelkmans, Wiesje
    Bouwman, Femke
    Groot, Colin
    van Maurik, Ingrid
    Zwan, Marissa
    Yaqub, Maqsood
    Barkhof, Frederik
    Lammertsma, Adriaan A.
    Biessels, Geert Jan
    Scheltens, Philip
    van Berckel, Bart N.
    van der Flier, Wiesje M.
    ALZHEIMERS & DEMENTIA, 2019, 15 (11) : 1458 - 1467
  • [8] Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria
    Grundman, Michael
    Johnson, Keith A.
    Lu, Ming
    Siderowf, Andrew
    Dell'Agnello, Grazia
    Arora, Anupa K.
    Skovronsky, Daniel M.
    Mintun, Mark A.
    Pontecorvo, Michael J.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2016, 41 (1-2) : 80 - 92
  • [9] Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
    Konstantinos Chiotis
    Stephen F. Carter
    Karim Farid
    Irina Savitcheva
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1492 - 1506
  • [10] Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria
    Maria Trivino-Ibanez, Eva
    Sanchez-Vano, Raquel
    Sopena-Novales, Pablo
    Carlos Romero-Fabrega, Juan
    Rodriguez-Fernandez, Antonio
    Carnero Pardo, Cristobal
    Martinez Lozano, Maria Dolores
    Gomez-Rio, Manuel
    MEDICINE, 2019, 98 (29) : e16509
12